Research Article
Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls
Kathryn L. Terry, Stalo Karageorgi, Yurii B. Shvetsov, Melissa A. Merritt, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Rachel Palmieri Weber, Lucy Akushevich, Wei-Hsuan Lo-Ciganic, Kara Cushing-Haugen, Weiva Sieh, Kirsten Moysich, Jennifer A. Doherty, Christina M. Nagle, Andrew Berchuck, Celeste L. Pearce, Malcolm Pike, Roberta B. Ness, Penelope M. Webb, for the Australian Cancer Study (Ovarian Cancer), and the Australian Ovarian Cancer Study Group;, Mary Anne Rossing, Joellen Schildkraut, Harvey Risch and Marc T. Goodman; on behalf of the Ovarian Cancer Association Consortium
Kathryn L. Terry
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Stalo Karageorgi
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Yurii B. Shvetsov
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Melissa A. Merritt
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Galina Lurie
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Pamela J. Thompson
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Michael E. Carney
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Rachel Palmieri Weber
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Lucy Akushevich
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Wei-Hsuan Lo-Ciganic
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Kara Cushing-Haugen
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Weiva Sieh
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Kirsten Moysich
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Jennifer A. Doherty
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Christina M. Nagle
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Andrew Berchuck
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Celeste L. Pearce
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Malcolm Pike
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Roberta B. Ness
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Penelope M. Webb
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Mary Anne Rossing
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Joellen Schildkraut
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Harvey Risch
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
Marc T. Goodman
Obstetrics and Gynecology Epidemiology Center, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Cancer Center, University of Hawaii, Honolulu, Hawaii; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Department of Health Research and Policy, Stanford University, Stanford, California; Departments of Community and Family Medicine and Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; University of Texas School of Public Health, Houston, Texas; and Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
DOI: 10.1158/1940-6207.CAPR-13-0037 Published August 2013
Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 8, pp. 811-821
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 5, 2013
- Revision received April 23, 2013
- Accepted May 21, 2013
- Published first June 12, 2013.
Article Versions
- Previous version (June 12, 2013 - 06:39).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Kathryn L. Terry1,3,4,
- Stalo Karageorgi2,
- Yurii B. Shvetsov5,
- Melissa A. Merritt4,
- Galina Lurie5,
- Pamela J. Thompson6,
- Michael E. Carney5,
- Rachel Palmieri Weber9,
- Lucy Akushevich6,
- Wei-Hsuan Lo-Ciganic11,
- Kara Cushing-Haugen12,
- Weiva Sieh8,
- Kirsten Moysich13,
- Jennifer A. Doherty12,15,
- Christina M. Nagle16,
- Andrew Berchuck10,
- Celeste L. Pearce7,
- Malcolm Pike7,14,
- Roberta B. Ness17,
- Penelope M. Webb16,
- for the Australian Cancer Study (Ovarian Cancer), and the Australian Ovarian Cancer Study Group;,
- Mary Anne Rossing12,
- Joellen Schildkraut9,
- Harvey Risch18, and
- Marc T. Goodman6; on behalf of the Ovarian Cancer Association Consortium
- Authors' Affiliations: 1Obstetrics and Gynecology Epidemiology Center, 2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; 3Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; 4Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 5Cancer Center, University of Hawaii, Honolulu, Hawaii; 6Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; 7Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; 8Department of Health Research and Policy, Stanford University, Stanford, California; Departments of 9Community and Family Medicine and 10Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; 11Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; 12Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 13Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo; 14Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 15Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Dartmouth Medical School, Hanover, New Hampshire; 16Gynaecological Cancers Group, Queensland Institute of Medical Research, Brisbane, Queensland, Australia; 17University of Texas School of Public Health, Houston, Texas; and 18Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
- Corresponding Author:
Kathryn L. Terry, Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, 221 Longwood Avenue, RFB 368, Boston, MA 02115. Phone: 617-732-8596; Fax: 617-732-4899; E-mail: kterry{at}partners.org
August 2013
Volume 6, Issue 8
Volume 6, Issue 8
Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls
Kathryn L. Terry, Stalo Karageorgi, Yurii B. Shvetsov, Melissa A. Merritt, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Rachel Palmieri Weber, Lucy Akushevich, Wei-Hsuan Lo-Ciganic, Kara Cushing-Haugen, Weiva Sieh, Kirsten Moysich, Jennifer A. Doherty, Christina M. Nagle, Andrew Berchuck, Celeste L. Pearce, Malcolm Pike, Roberta B. Ness, Penelope M. Webb, for the Australian Cancer Study (Ovarian Cancer), and the Australian Ovarian Cancer Study Group;, Mary Anne Rossing, Joellen Schildkraut, Harvey Risch and Marc T. Goodman on behalf of the Ovarian Cancer Association Consortium
Cancer Prev Res August 1 2013 (6) (8) 811-821; DOI: 10.1158/1940-6207.CAPR-13-0037
Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls
Kathryn L. Terry, Stalo Karageorgi, Yurii B. Shvetsov, Melissa A. Merritt, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Rachel Palmieri Weber, Lucy Akushevich, Wei-Hsuan Lo-Ciganic, Kara Cushing-Haugen, Weiva Sieh, Kirsten Moysich, Jennifer A. Doherty, Christina M. Nagle, Andrew Berchuck, Celeste L. Pearce, Malcolm Pike, Roberta B. Ness, Penelope M. Webb, for the Australian Cancer Study (Ovarian Cancer), and the Australian Ovarian Cancer Study Group;, Mary Anne Rossing, Joellen Schildkraut, Harvey Risch and Marc T. Goodman on behalf of the Ovarian Cancer Association Consortium
Cancer Prev Res August 1 2013 (6) (8) 811-821; DOI: 10.1158/1940-6207.CAPR-13-0037
Jump to section
Advertisement